Comparing the Efficacy of High-Power and Low-Power Laser Therapy in the Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients with Acute Lymphoblastic Leukemia: A Randomized Controlled Trial
This randomized controlled trial involving 30 pediatric patients with acute lymphoblastic leukemia demonstrates that both high-power and low-power laser therapies are safe and effective in significantly reducing the severity of chemotherapy-induced oral mucositis compared to placebo, with no statistically significant difference in efficacy between the two laser modalities.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For children undergoing treatment for a specific type of blood cancer, the chemotherapy drugs that fight the disease often bring a painful side effect: sores inside the mouth. This condition, known as oral mucositis, occurs when the powerful medications damage the delicate lining of the mouth, leading to inflammation, ulceration, and severe pain that can make eating and swallowing nearly impossible. While the body eventually heals these wounds once the treatment stops, the period of suffering can be debilitating, sometimes forcing doctors to pause life-saving therapy or requiring strong pain medication. In recent years, doctors have turned to light-based therapies to help manage this pain and speed up healing. These treatments use specific wavelengths of light to stimulate the body's natural repair processes, reduce inflammation, and calm nerve activity, offering a way to soothe the mouth without adding more drugs to a child's system.
A new study conducted at the Children's University Hospital in Damascus, Syria, set out to compare two different ways of using this light therapy against a fake treatment. The researchers focused on thirty children, aged three to thirteen, who were being treated for acute lymphoblastic leukemia and had developed mouth sores as a result. The children were divided into three equal groups. One group received high-power laser therapy, another received low-level laser therapy, and the third group received a placebo, where a device looked and sounded exactly like the real treatment but emitted no light energy. All treatments were applied once a day for four consecutive days, and the children were checked at the start of the study, at the end of the four-day treatment, and again one week later to see how their mouths had healed.
The high-power treatment was applied from outside the skin, shining on the cheeks, lips, and neck area without touching the surface. It used a stronger beam of light for a total of six hundred and sixty joules of energy per session. The low-power treatment was applied directly inside the mouth, touching the gums, tongue, and inner cheeks, using a much gentler beam that delivered sixty joules of energy. The placebo group underwent the exact same routine with the same device, ensuring that neither the children nor the staff assessing the results knew who was getting the real light until the data was analyzed. Throughout the study, all children received the same standard care, including oral hygiene and nutritional support, so that any differences in healing could be attributed to the light treatments alone.
The results showed that both types of laser therapy worked significantly better than the fake treatment. By the fourth day, when the treatments ended, and again by the eleventh day, the children who received either the high-power or low-level light had far fewer and less severe sores than those in the placebo group. The doctors measured the severity of the sores using two different scales: one that graded the physical damage visible to a clinician, and another that asked about the child's ability to eat, drink, and swallow, as well as their pain levels. On both measures, the laser groups showed clear improvement. Interestingly, while the high-power laser group showed slightly better numbers than the low-power group, the difference between the two real treatments was not statistically significant. This means that while the stronger light appeared to help a bit more, the study could not prove with certainty that it was truly superior to the gentler light.
What this research confirms is that using light therapy is a safe and effective way to help children recover from chemotherapy-induced mouth sores. Neither the high-power nor the low-level treatment caused any harmful side effects, and every child who started the study finished it. The findings suggest that shining light on the affected areas, whether from the outside of the face or directly inside the mouth, can accelerate healing and reduce pain. While the high-power laser offered a promising trend toward faster recovery, the study indicates that both methods are valuable tools for doctors. This work provides important evidence that light-based care can be a standard part of supportive treatment for young cancer patients, helping them endure their chemotherapy with greater comfort and fewer interruptions to their vital medical care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.